Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of HCW Biologics Inc (NASDAQ: HCWB) closed at $4.5 in the last session, up 6.64% from day before closing price of $4.22. In other words, the price has increased by $6.64 from its previous closing price. On the day, 3.55 million shares were traded. HCWB stock price reached its highest trading level at $5.47 during the session, while it also had its lowest trading level at $3.55.
Ratios:
We take a closer look at HCWB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.07 and its Current Ratio is at 0.07.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 16 ’25 when Wong Hing C bought 8,054 shares for $7.45 per share. The transaction valued at 60,002 led to the insider holds 501,911 shares of the business.
Winer Gary M bought 1,342 shares of HCWB for $9,998 on May 16 ’25. The Director now owns 4,075 shares after completing the transaction at $7.45 per share. On May 16 ’25, another insider, GARRETT SCOTT T, who serves as the Director of the company, bought 13,423 shares for $7.45 each. As a result, the insider paid 100,001 and bolstered with 25,505 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCWB now has a Market Capitalization of 9356310 and an Enterprise Value of 19308574. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.49. Its current Enterprise Value per Revenue stands at 13.361 whereas that against EBITDA is -0.785.
Stock Price History:
The Beta on a monthly basis for HCWB is 0.71, which has changed by -0.8269231 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, HCWB has reached a high of $100.80, while it has fallen to a 52-week low of $4.00. The 50-Day Moving Average of the stock is -34.45%, while the 200-Day Moving Average is calculated to be -69.06%.
Shares Statistics:
According to the various share statistics, HCWB traded on average about 669.34K shares per day over the past 3-months and 423280 shares per day over the past 10 days. A total of 2.41M shares are outstanding, with a floating share count of 1.16M. Insiders hold about 52.09% of the company’s shares, while institutions hold 1.20% stake in the company. Shares short for HCWB as of 1749772800 were 13034 with a Short Ratio of 0.02, compared to 1747267200 on 288435. Therefore, it implies a Short% of Shares Outstanding of 13034 and a Short% of Float of 0.8.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
According to 1 analysts, the current quarter’s revenue is expected to be $7M. It ranges from a high estimate of $7M to a low estimate of $7M. As of the current estimate, HCW Biologics Inc’s year-ago sales were $618.85k
A total of 1 analysts have provided revenue estimates for HCWB’s current fiscal year. The highest revenue estimate was $7M, while the lowest revenue estimate was $7M, resulting in an average revenue estimate of $7M. In the same quarter a year ago, actual revenue was $2.57M
